Interpace Biosciences Inc
OTC:IDXG
Interpace Biosciences Inc
Change in Working Capital
Interpace Biosciences Inc
Change in Working Capital Peer Comparison
Competitive Change in Working Capital Analysis
Latest Figures & CAGR of Competitors
Company | Change in Working Capital | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Interpace Biosciences Inc
OTC:IDXG
|
Change in Working Capital
-$1.1m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
24%
|
CAGR 10-Years
16%
|
|
DaVita Inc
NYSE:DVA
|
Change in Working Capital
-$528.8m
|
CAGR 3-Years
-29%
|
CAGR 5-Years
-34%
|
CAGR 10-Years
N/A
|
|
Quest Diagnostics Inc
NYSE:DGX
|
Change in Working Capital
-$79m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
13%
|
|
CVS Health Corp
NYSE:CVS
|
Change in Working Capital
-$122.1B
|
CAGR 3-Years
-13%
|
CAGR 5-Years
-25%
|
CAGR 10-Years
-24%
|
|
Cigna Corp
NYSE:CI
|
Change in Working Capital
$3B
|
CAGR 3-Years
5%
|
CAGR 5-Years
34%
|
CAGR 10-Years
N/A
|
|
Laboratory Corporation of America Holdings
NYSE:LH
|
Change in Working Capital
-$474m
|
CAGR 3-Years
3%
|
CAGR 5-Years
-28%
|
CAGR 10-Years
-5%
|
See Also
What is Interpace Biosciences Inc's Change in Working Capital?
Change in Working Capital
-1.1m
USD
Based on the financial report for Mar 31, 2024, Interpace Biosciences Inc's Change in Working Capital amounts to -1.1m USD.
What is Interpace Biosciences Inc's Change in Working Capital growth rate?
Change in Working Capital CAGR 10Y
16%
Over the last year, the Change in Working Capital growth was 60%.